Mithra Pharmaceuticals

{
  "events": [
    {
      "kind": "director_out",
      "role": "directeur",
      "person": {
        "rrn": "BCE 0678.747.008",
        "name": "Castors Development SA",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "de_plein_droit_dissolution",
      "subkind": "rectification",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2024-03-05",
      "evidence_quote": "D\u00E9mission de Castors Development SA avec effet imm\u00E9diat et remplacement par cooptation",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_in",
      "role": "co-CEOs",
      "person": {
        "rrn": null,
        "name": "C. Mar\u00E9chal",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "renewal",
      "via_org": {
        "kbo": null,
        "name": "CMM\u0026C SRL",
        "address": null,
        "country": null,
        "legal_form": "SRL"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": "2024-03-04",
      "evidence_quote": "d\u00E9signer provisoirement, en qualit\u00E9 de co-CEOs, le CFO de la Soci\u00E9t\u00E9, CMM\u0026C SRL (ayant pour repr\u00E9sentant permanent C. Mar\u00E9chal)",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_agm_year",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_in",
      "role": "co-CEOs",
      "person": {
        "rrn": null,
        "name": "Xavier Paoli",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "renewal",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2024-03-04",
      "evidence_quote": "d\u00E9signer provisoirement, en qualit\u00E9 de co-CEOs, le CFO de la Soci\u00E9t\u00E9, CMM\u0026C SRL (ayant pour repr\u00E9sentant permanent C. Mar\u00E9chal) et le COO, Xavier Paoli",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_agm_year",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_in",
      "role": "co-CEOs",
      "person": {
        "rrn": null,
        "name": "J.-M. Foidart",
        "address": null,
        "birth_date": null,
        "profession": "Professeur",
        "birth_place": null
      },
      "reason": null,
      "subkind": "renewal",
      "via_org": {
        "kbo": null,
        "name": "Eva Consulting SRL",
        "address": null,
        "country": null,
        "legal_form": "SRL"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": "2024-03-04",
      "evidence_quote": "assist\u00E9s dans l\u0027exercice de leurs fonctions par le Pr\u00E9sident du Conseil, Eva Consulting SRL (dont le repr\u00E9sentant permanent est le Professeur J.-M. Foidart)",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_agm_year",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_in",
      "role": "co-CEOs",
      "person": {
        "rrn": null,
        "name": "C. Mar\u00E9chal",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "renewal",
      "via_org": {
        "kbo": null,
        "name": "CMM\u0026C SRL",
        "address": null,
        "country": null,
        "legal_form": "SRL"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": "2024-03-04",
      "evidence_quote": "Confirmer l\u0027organisation telle que d\u00E9cid\u00E9e lors de la r\u00E9union du Conseil du 4 mars, \u00E0 savoir de nommer provisoirement en qualit\u00E9 de co-d\u00E9l\u00E9gu\u00E9s \u00E0 la gestion journali\u00E8re (co-CEOs), le CFO de la Soci\u00E9t\u00E9, CMM\u0026C SRL (ayant pour repr\u00E9sentant C. Mar\u00E9chal)",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_agm_year",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_in",
      "role": "co-CEOs",
      "person": {
        "rrn": null,
        "name": "Xavier Paoli",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "renewal",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2024-03-04",
      "evidence_quote": "Confirmer l\u0027organisation telle que d\u00E9cid\u00E9e lors de la r\u00E9union du Conseil du 4 mars, \u00E0 savoir de nommer provisoirement en qualit\u00E9 de co-d\u00E9l\u00E9gu\u00E9s \u00E0 la gestion journali\u00E8re (co-CEOs), le CFO de la Soci\u00E9t\u00E9, CMM\u0026C SRL (ayant pour repr\u00E9sentant C. Mar\u00E9chal) et le COO, Xavier Paoli",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_agm_year",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "decharge_granted",
      "role": null,
      "person": null,
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "le Conseil donne mandat au Corporate Secretary et aux Legal Counsel de la Soci\u00E9t\u00E9, Me. Fanny Rozenberg, Mme Justine Pahaut et Mme Fanny Henrard, avec pouvoir de subd\u00E9l\u00E9gation, afin de remplir toutes les formalit\u00E9s et effectuer toutes les d\u00E9marches n\u00E9cessaires",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "decharge_granted",
      "role": null,
      "person": {
        "rrn": null,
        "name": "Fanny Rozenberg",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "le Conseil donne mandat au Corporate Secretary et aux Legal Counsel de la Soci\u00E9t\u00E9, Me. Fanny Rozenberg, Mme Justine Pahaut et Mme Fanny Henrard, avec pouvoir de subd\u00E9l\u00E9gation",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "decharge_granted",
      "role": null,
      "person": {
        "rrn": null,
        "name": "Justine Pahaut",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "le Conseil donne mandat au Corporate Secretary et aux Legal Counsel de la Soci\u00E9t\u00E9, Me. Fanny Rozenberg, Mme Justine Pahaut et Mme Fanny Henrard, avec pouvoir de subd\u00E9l\u00E9gation",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "decharge_granted",
      "role": null,
      "person": {
        "rrn": null,
        "name": "Fanny Henrard",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "le Conseil donne mandat au Corporate Secretary et aux Legal Counsel de la Soci\u00E9t\u00E9, Me. Fanny Rozenberg, Mme Justine Pahaut et Mme Fanny Henrard, avec pouvoir de subd\u00E9l\u00E9gation",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2024-04-10",
    "filing_date": "2024-03-29",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decisions": [
    {
      "body": "conseil_d_administration",
      "date": "2024-03-04",
      "unanimous": true
    },
    {
      "body": "conseil_d_administration",
      "date": "2024-03-05",
      "unanimous": true
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Fanny HENRARD",
    "org_rep_person_name": null,
    "person_role_at_subject": "Mandataire"
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Castors Development SA",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "C2M4E SRL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "co-CEO",
      "person": {
        "rrn": null,
        "name": "Xavier Paoli",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "co-CEO",
      "person": {
        "rrn": null,
        "name": "CMM\u0026C SRL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "directeur g\u00E9n\u00E9ral",
      "person": {
        "rrn": null,
        "name": "CEO",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  }
}

{
  "events": [
    {
      "kind": "warrant_issuance",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "inschrijvingsrechten_uitgifte",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Geoffrey GAUTHY",
    "firm_city": null,
    "firm_name": "GAUTHY, JACQUES \u0026 ROLANS \u2013 Soci\u00E9t\u00E9 Notariale",
    "office_city": "Herstal",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2023-12-22",
    "filing_date": "2023-12-20",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "raad_van_bestuur",
    "act_date": "2023-12-19",
    "unanimous": null,
    "under_authorized_capital": true,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "MITHRA PHARMACEUTICALS",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition de l\u0027assembl\u00E9e comprenant les procurations, le rapport du CA et le rapport du commissaire",
    "la coordination des statuts"
  ],
  "shareholders_after": [],
  "share_classes_after": []
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "administrateur ind\u00E9pendant",
      "person": {
        "rrn": null,
        "name": "Ribono SRL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur ind\u00E9pendant",
      "person": {
        "rrn": null,
        "name": "Inge Beernaert",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur ind\u00E9pendant",
      "person": {
        "rrn": null,
        "name": "Life Science Strategy Consulting SRL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur ind\u00E9pendant",
      "person": {
        "rrn": null,
        "name": "Gaudeto SRL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "administrateur ind\u00E9pendant",
      "person": {
        "rrn": null,
        "name": "Life Science Strategy Consulting SRL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "administrateur ind\u00E9pendant",
      "person": {
        "rrn": null,
        "name": "Gaudeto SRL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "administrateur ind\u00E9pendant",
      "person": {
        "rrn": null,
        "name": "Inge Beernaert",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "administrateur ind\u00E9pendant",
      "person": {
        "rrn": null,
        "name": "Ribono SRL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur ind\u00E9pendant",
      "person": {
        "rrn": null,
        "name": "Castors Development SA",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Eva Consulting SRL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Alius Modi SRL",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Inge Beernaert",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Inge Beernaert",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
      "person": {
        "rrn": null,
        "name": "David Horn Solomon",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
      "person": {
        "rrn": null,
        "name": "Bronzet Management",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Inge Beernaert",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "de_plein_droit_dissolution",
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Le Conseil d\u0027administration prend acte de la d\u00E9mission de Madame Inge Beernaert en sa qualit\u00E9 d\u0027administratrice",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Inge Beernaert",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "successor_conditional",
      "via_org": {
        "kbo": "0543.653.920",
        "name": "Inge Beernaert BV",
        "address": null,
        "country": null,
        "legal_form": "BV"
      },
      "statutory": "coopted",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "approuve le remplacement de celle-ci par cooptation par la soci\u00E9t\u00E9 Inge Beernaert BV",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "corporate_secretary",
      "person": {
        "rrn": null,
        "name": "Fanny Rozenberg",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "le Conseil donne mandat au Corporate Secretary de la Soci\u00E9t\u00E9, Me. Fanny Rozenberg, avec pouvoir de subd\u00E9l\u00E9gation",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_in",
      "role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
      "person": {
        "rrn": null,
        "name": "David Horn Solomon",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "renewal",
      "via_org": {
        "kbo": "0804.886.105",
        "name": "Bronzet Management",
        "address": null,
        "country": null,
        "legal_form": "SRL"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "le Conseil d\u0027administration acte le remplacement de M. David Horn Solomon au poste de d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2023-12-07",
    "filing_date": "2023-09-21",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decisions": [
    {
      "body": "conseil_d_administration",
      "date": "2023-09-21",
      "unanimous": null
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "FANNY ROZENBERG",
    "org_rep_person_name": null,
    "person_role_at_subject": "COUNSEL GENERAL"
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}

{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  },
  "legal_form_change": {
    "new": "",
    "old": "Soci\u00E9t\u00E9 anonyme",
    "changed": false
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 50212360.13,
      "delta_eur": 20000000.000000004,
      "before_eur": 30212360.13,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": null,
      "delta_eur": 20000000.0,
      "before_eur": null,
      "subscribers": [
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "Investisseur",
          "share_class": null,
          "liberation_pct": 100.0,
          "contribution_kind": "geld",
          "n_shares_subscribed": 10000000,
          "contribution_amount_eur": 20000000.0
        }
      ],
      "share_emission": {
        "agio_eur": 20000000.0,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 10000000,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 2.0
      },
      "decrease_purpose": null,
      "contribution_type": "geld",
      "paid_up_delta_eur": 20000000.0,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": "create"
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": "nominal",
        "share_class": null,
        "n_new_shares": 2200000,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 7800000,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Geoffrey GAUTHY",
    "firm_city": null,
    "firm_name": "GAUTHY, JACQUES \u0026 ROLANS \u2013 Soci\u00E9t\u00E9 Notariale",
    "office_city": "Herstal",
    "is_associated": true
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2023-08-30",
    "filing_date": "2023-08-28",
    "act_kind_objet": "Objet de l\u0027acte : CAPITAL, ACTIONS"
  },
  "decision": {
    "body": "raad_van_bestuur",
    "act_date": "2023-08-28",
    "unanimous": null,
    "under_authorized_capital": true,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "MITHRA PHARMACEUTICALS",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition de l\u2019assembl\u00E9e comprenant les procurations, le rapport du CA et le rapport du commissaire",
    "la coordination des statuts"
  ],
  "shareholders_after": [
    {
      "kbo": null,
      "pct": null,
      "kind": "org",
      "name": "Investisseur",
      "role": "aandeelhouder",
      "n_shares": 10000000,
      "share_class": null
    }
  ],
  "share_classes_after": [
    {
      "n_shares": 68587058,
      "class_name": "actions sans d\u00E9signation de valeur nominale",
      "capital_share_eur": 50212360.13,
      "voting_rights_per_share": null
    }
  ]
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
      "person": {
        "rrn": null,
        "name": "Leon Van Rompay",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
      "person": {
        "rrn": null,
        "name": "David H. Solomon",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "MITHRA PHARMACEUTICALS"
  }
}

{
  "stage": null,
  "notary": {
    "name": "Geoffrey GAUTHY",
    "firm_city": null,
    "firm_name": "GAUTHY, JACQUES \u0026 ROLANS \u2013 Soci\u00E9t\u00E9 Notariale",
    "office_city": "Herstal",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2023-06-27",
    "filing_date": "2023-06-23",
    "act_kind_objet": "DIVERS"
  },
  "decision": {
    "body": "raad_van_bestuur",
    "act_date": "2023-06-21",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0466.526.646",
        "name": "Mithra Pharmaceuticals",
        "role": "contributor",
        "address": "Rue Saint-Georges 5, 4000 Li\u00E8ge",
        "is_foreign": false,
        "legal_form": "Soci\u00E9t\u00E9 anonyme",
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "7:179",
      "7:181",
      "7:186",
      "7:197",
      "7:198"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": null,
    "real_estate_included": false,
    "patrimony_description": "Apport en nature de cr\u00E9ances dues par la soci\u00E9t\u00E9, issues des Conventions Modifi\u00E9es (pr\u00EAts convertibles seniors et accord de conversion), en vue d\u0027une augmentation de capital et d\u0027\u00E9mission de nouvelles actions.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals",
    "legal_form": "Soci\u00E9t\u00E9 anonyme"
  },
  "detected_kind_raw": "capital_shares",
  "publication_proxy": {
    "kind": "org",
    "org_kbo": null,
    "org_name": "GAUTHY, JACQUES \u0026 ROLANS \u2013 Soci\u00E9t\u00E9 Notariale",
    "person_name": null,
    "org_rep_person_name": "Geoffrey GAUTHY"
  },
  "summary_narrative": "Le conseil d\u0027administration de Mithra Pharmaceuticals a d\u00E9cid\u00E9 d\u0027augmenter le capital de la soci\u00E9t\u00E9 par apport en nature de cr\u00E9ances dues par celle-ci, issues de conventions de pr\u00EAts convertibles et d\u0027accords de conversion conclus avec des fonds g\u00E9r\u00E9s par Highbridge Capital Management et Whitebox Advisors. L\u0027op\u00E9ration, soumise \u00E0 des conditions suspensives, pr\u00E9voit l\u0027\u00E9mission de nouvelles actions en contrepartie de ces apports, dont le nombre et le prix d\u0027\u00E9mission seront d\u00E9termin\u00E9s ult\u00E9rieurement. Le conseil a \u00E9galement nomm\u00E9 un comit\u00E9 charg\u00E9 de mettre en \u0153uvre l\u0027op\u00E9ration, y compris la pr\u00E9para",
  "co_filed_documents": [
    "exp\u00E9dition de l\u2019acte comprenant les procurations, le rapport du CA et le rapport du commissaire.",
    "la coordination des statuts."
  ],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": "capital_shares"
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 42891360.13,
      "delta_eur": 7267813.260000005,
      "before_eur": 35623546.87,
      "contribution_type": "natura"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 42891360.13,
      "delta_eur": 42891360.13,
      "before_eur": 0.0,
      "_arith_derived": "before",
      "share_emission": {
        "agio_eur": 660707.26,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 58587058,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "inschrijvingsrechten_uitgifte",
      "paid_up_delta_eur": 42891360.13,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Geoffrey GAUTHY",
    "firm_city": null,
    "firm_name": "GAUTHY, JACQUES \u0026 ROLANS \u2013 Soci\u00E9t\u00E9 Notariale",
    "office_city": "Herstal",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2023-06-27",
    "filing_date": "2023-06-23",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "conseil_d\u0027administration",
    "act_date": "2023-06-23",
    "unanimous": null,
    "under_authorized_capital": true,
    "underlying_resolution_date": "2023-06-21"
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition de l\u2019acte",
    "la coordination des statuts"
  ],
  "shareholders_after": [],
  "share_classes_after": []
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 42500000.8,
      "delta_eur": 2500000.8,
      "before_eur": 40000000.0,
      "subscribers": [
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "Pr\u00EAteurs",
          "share_class": null,
          "liberation_pct": 100.0,
          "contribution_kind": "pret_convertible",
          "n_shares_subscribed": 58495395,
          "contribution_amount_eur": 2500000.8
        }
      ],
      "share_emission": {
        "agio_eur": 1668073.08,
        "share_form": "pair_comptable",
        "share_class": null,
        "n_new_shares": 58495395,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "inschrijvingsrechten_uitgifte",
      "paid_up_delta_eur": 2500000.8,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": "convert_to_distributable"
    }
  ],
  "notary": {
    "name": "Geoffrey GAUTHY",
    "firm_city": null,
    "firm_name": "GAUTHY, JACQUES \u0026 ROLANS \u2013 Soci\u00E9t\u00E9 Notariale",
    "office_city": "Herstal",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2023-05-31",
    "filing_date": "2023-05-26",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "conseil_d_administration",
    "act_date": "2023-05-25",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": "2023-05-24"
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "MITHRA PHARMACEUTICALS",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition de l\u2019acte",
    "la coordination des statuts"
  ],
  "shareholders_after": [],
  "share_classes_after": []
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 42824254.0,
      "delta_eur": 2000000.0,
      "before_eur": 40824254.0,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": null,
      "delta_eur": 2500000.8,
      "before_eur": null,
      "share_emission": {
        "agio_eur": 1668073.08,
        "share_form": "pair_comptable",
        "share_class": null,
        "n_new_shares": 1136364,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 2.2
      },
      "decrease_purpose": null,
      "contribution_type": "geld",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Geoffrey GAUTHY",
    "firm_city": null,
    "firm_name": "GAUTHY, JACQUES \u0026 ROLANS \u2013 Soci\u00E9t\u00E9 Notariale",
    "office_city": "Herstal",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2023-05-30",
    "filing_date": "2023-05-25",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "conseil_d\u0027administration",
    "act_date": "2023-05-24",
    "unanimous": null,
    "under_authorized_capital": true,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "MITHRA PHARMACEUTICALS",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition de l\u0027acte comprenant les procurations, le rapport du CA et le rapport du commissaire",
    "la coordination des statuts"
  ],
  "shareholders_after": [],
  "share_classes_after": []
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 2500000.8,
      "delta_eur": null,
      "before_eur": null,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 41992326.28,
      "delta_eur": 208947.6099999994,
      "before_eur": 41783378.67,
      "contribution_type": "natura"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 41992326.28,
      "delta_eur": 641289.61,
      "before_eur": 41351036.67,
      "_arith_derived": "before",
      "share_emission": {
        "agio_eur": 432341.68,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 57359031,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "natura",
      "paid_up_delta_eur": 641289.61,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": "convert_to_apports_non_appeles"
    }
  ],
  "notary": {
    "name": "Geoffrey GAUTHY",
    "firm_city": null,
    "firm_name": "GAUTHY, JACQUES \u0026 ROLANS \u2013 Soci\u00E9t\u00E9 Notariale",
    "office_city": "Herstal",
    "is_associated": true
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2023-05-16",
    "filing_date": "2023-05-12",
    "act_kind_objet": "Objet de l\u0027acte : CAPITAL, ACTIONS"
  },
  "decision": {
    "body": "assembl\u00E9e_generale_extraordinaire",
    "act_date": "2023-05-11",
    "unanimous": null,
    "under_authorized_capital": true,
    "underlying_resolution_date": "2022-10-21"
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition de l\u2019acte",
    "la coordination des statuts"
  ],
  "shareholders_after": [],
  "share_classes_after": []
}

{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  },
  "legal_form_change": {
    "new": "Soci\u00E9t\u00E9 anonyme",
    "old": "Soci\u00E9t\u00E9 anonyme",
    "changed": false
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 41783378.35,
      "delta_eur": 1854570.7199999988,
      "before_eur": 39928807.63,
      "contribution_type": "natura"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 41783378.35,
      "delta_eur": 353258.75,
      "before_eur": 41430119.6,
      "_arith_derived": "before",
      "share_emission": {
        "agio_eur": 1501311.97,
        "share_form": "pair_comptable",
        "share_class": null,
        "n_new_shares": 482528,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "natura",
      "paid_up_delta_eur": 353258.75,
      "n_shares_destroyed": null,
      "not_yet_called_eur": 1501311.97,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": "convert_to_apports_non_appeles"
    }
  ],
  "notary": {
    "name": "Jean-Michel GAUTHY",
    "firm_city": null,
    "firm_name": "GAUTHY, JACQUES \u0026 ROLANS \u2013 Soci\u00E9t\u00E9 Notariale",
    "office_city": "Herstal",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2023-03-15",
    "filing_date": "2023-03-13",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "assembl\u00E9e_generale_extraordinaire",
    "act_date": "2023-03-13",
    "unanimous": null,
    "under_authorized_capital": true,
    "underlying_resolution_date": "2022-10-21"
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition de l\u2019acte",
    "la coordination des statuts"
  ],
  "shareholders_after": [],
  "share_classes_after": []
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 36960159.8,
      "delta_eur": 721159.799999997,
      "before_eur": 36239000,
      "contribution_type": "natura"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 45220980.0,
      "delta_eur": 4211980.0,
      "before_eur": 41009000.0,
      "share_emission": {
        "agio_eur": 519012.35,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 56591094,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "natura",
      "paid_up_delta_eur": 721159.8,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Jean-Michel GAUTHY",
    "firm_city": null,
    "firm_name": "GAUTHY, JACQUES \u0026 ROLANS \u2013 Soci\u00E9t\u00E9 Notariale",
    "office_city": "Herstal",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2023-02-16",
    "filing_date": "2023-02-14",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "assembl\u00E9e_generale_extraordinaire",
    "act_date": "2023-02-13",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": "2022-10-21"
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "MITHRA PHARMACEUTICALS",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition de l\u2019acte",
    "la coordination des statuts"
  ],
  "shareholders_after": [],
  "share_classes_after": []
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 41227972.15,
      "delta_eur": 8227972.1499999985,
      "before_eur": 33000000,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals"
  }
}

{
  "events": [
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Christophe Pelzer",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "renewal",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "il a \u00E9t\u00E9 d\u00E9cid\u00E9 de nommer Monsieur Christophe Pelzer en tant que repr\u00E9sentant permanent \u00E0 partir de l\u0027exercice comptable 2022, en remplacement de Monsieur C\u00E9dric Antonelli, dans le cadre du mandat de commissaire de MITHRA PHARMACEUTICALS SA.",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_agm_year",
        "value": "2022"
      },
      "rep_rotation_new_rep": "Christophe Pelzer",
      "rep_rotation_old_rep": "C\u00E9dric Antonelli",
      "effective_date_qualifier": null
    },
    {
      "kind": "decharge_granted",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "C\u00E9dric Antonelli",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": null,
    "filing_date": "2022-12-28",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decisions": [
    {
      "body": "enig_aandeelhouder_schriftelijk",
      "date": "2022-12-28",
      "unanimous": null
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "BINAL DE L\u0027ENTREPRISE ONASION LIEGE",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": null,
    "org_name": "Van Rompay Management BV",
    "person_name": null,
    "org_rep_person_name": "L\u00E9on Van Rompay",
    "person_role_at_subject": null
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "representant permanent commissaire",
      "person": {
        "rrn": null,
        "name": "Christophe Pelzer",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "representant permanent commissaire",
      "person": {
        "rrn": null,
        "name": "C\u00E9dric Antonelli",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "MITHRA PHARMACEUTICALS SA"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 41227972.15,
      "delta_eur": 1165900.0,
      "before_eur": 40062072.15,
      "_arith_derived": "before",
      "share_emission": {
        "agio_eur": 974089.8,
        "share_form": "pair_comptable",
        "share_class": null,
        "n_new_shares": 56314974,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "numeraire",
      "paid_up_delta_eur": 1165900.2,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": "convert_to_apports_non_appeles"
    }
  ],
  "notary": {
    "name": "Jean-Michel GAUTHY",
    "firm_city": null,
    "firm_name": "GAUTHY \u0026 JACQUES \u2013 Notaires Associ\u00E9s",
    "office_city": "Herstal",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2023-01-06",
    "filing_date": "2023-01-04",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "conseil_d_administration",
    "act_date": "2022-12-30",
    "unanimous": null,
    "under_authorized_capital": true,
    "underlying_resolution_date": "2020-05-22"
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition de l\u2019acte comprenant 1 procuration et l\u2019attestation bancaire",
    "la coordination des statuts"
  ],
  "shareholders_after": [],
  "share_classes_after": []
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": null,
      "delta_eur": 2629403.05,
      "before_eur": null,
      "share_emission": {
        "agio_eur": 2128555.14,
        "share_form": "pair_comptable",
        "share_class": null,
        "n_new_shares": 56052974,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "apports_en_nature",
      "paid_up_delta_eur": 500847.91,
      "n_shares_destroyed": null,
      "not_yet_called_eur": 2128555.14,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": "convert_to_apports_non_appeles"
    }
  ],
  "notary": {
    "name": "Jean-Michel GAUTHY",
    "firm_city": null,
    "firm_name": "GAUTHY \u0026 JACQUES \u2013 Notaires Associ\u00E9s",
    "office_city": "Herstal",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2022-12-28",
    "filing_date": "2022-12-23",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "assembl\u00E9e_generale_extraordinaire",
    "act_date": "2022-12-21",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": "2022-10-21"
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0466.526.646",
    "name_full": "Mithra Pharmaceuticals",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition de l\u2019acte",
    "la coordination des statuts"
  ],
  "shareholders_after": [],
  "share_classes_after": []
}